Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

Institut de Cancérologie de Lorraine

Status: Completed

Conditions: Pancreatic Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT02977702

ICL_2015_0003

Details and patient eligibility

About

The primary objective of this study was to validate Total Psoas Area (TPA) measurement as an independent prognostic factor of overall survival in patients with pancreatic adenocarcinoma. Secondary objective was to describe the evolution of the TPA during the follow-up.

Enrollment: 114 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients consecutive enrolled from January 2009 to December 2015 who underwent at least one chemotherapy for pancreatic adenocarcinoma, whatever the stage

Exclusion criteria

• A patient record captured outside the time frame from January 2009 to December 2015